Homozygous deletions of the TUSC3 gene have been revealed in vitro experiments on human prostate, lung, liver and colon cell lines, as well as lymph node tumour, breast and pancreatic cancer 24, 39, 41. This evidence concerns the gene TUSC3 and pancreatic neoplasm.